Comprehensive pan-cancer analysis reveals LAMA5 as a prognostic biomarker associated with tumor immunity in human cancers, with experimental validation in uveal melanoma
Year: 2026
Type: article
Abstract: Background LAMA5, encoding the laminin α5 chain, is a crucial component of the extracellular matrix implicated in cell adhesion, migration, and signaling. However, a systematic assessment of its pan-cancer prognostic and immunological roles remains elusive. Methods We conducted an integrative multi-omics analysis utilizing datasets from TCGA, GTEx, CPTAC, and cBioPortal to evaluate the expression landscape, genetic alterations, diagnostic and prognostic value, and association with tumor immunity of LAMA5 across 33 cancer types. Functional enrichment and pathway analyses were performed to decipher potential mechanisms. Correlations with immune cell infiltration, immunomodulator genes, and chemotherapeutic response were assessed. The biological functions of LAMA5 were further experimentally validated in uveal melanoma (UVM) cell lines through knockdown experiments. Results LAMA5 expression was dysregulated across multiple cancer types and was associated with clinicopathological features and survival outcomes in selected cancers, including UVM. Exploratory ROC analyses suggested tissue-level discriminatory potential in several cancers, particularly cholangiocarcinoma. LAMA5 expression was also associated with angiogenesis-, epithelial–mesenchymal transition-, inflammation-, and immune-related transcriptional features. Drug-response and CMap analyses identified exploratory pharmacological associations with LAMA5-related expression patterns. In vitro , LAMA5 knockdown significantly reduced the proliferative, migratory, and invasive capacities of UVM cells. Conclusion Our comprehensive pan-cancer study identifies LAMA5 as a prognostic biomarker associated with tumor progression and distinct immune microenvironment features across cancers. Functional experiments in UVM cells further support a tumor cell-intrinsic role for LAMA5 in proliferation, migration, and invasion. These findings highlight the biological and prognostic relevance of LAMA5 in UVM, while its therapeutic potential and possible immunoregulatory functions require further experimental validation.
Source: Frontiers in Oncology
Authors: Yang Liu(Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing), Brian Rossmiller(Data curation, Methodology, Writing – review & editing), FangXia Zhang(Data curation, Resources, Writing – review & editing), WenYan Fan(Data curation, Writing – review & editing)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: LAMA5, laminin alpha5, prognostic factors, antitumor immunity, uveal melanoma, pan-cancer analysis, extracellular matrix, immune cell infiltration, chemotherapy response, epithelial-mesenchymal transition, angiogenesis, tumor cell proliferation, migration and invasion, cholangiocarcinoma, drug response
Open Access status: gold
Estimated APC paid: $3,801
Funder: Ningxia Medical University
OpenAlex ID: W7234850992
